Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery

NCT01805856 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2164

Last updated 2013-03-06

No results posted yet for this study

Summary

The effectiveness of antimicrobial prophylaxis (AMP) for prevention of surgical site infection (SSI) following thyroid and parathyroid surgery remains uncertain. Present prospective randomized control study (Ito-RCT1) assessed the effectiveness of AMP in clean neck surgery associated with thyroid and parathyroid disease.

Conditions

  • Thyroid Disease
  • Parathyroid Disease

Interventions

DRUG

PIPC piperacillin sodium

DRUG

CEZ, cefazolin sodium

Sponsors & Collaborators

  • Ito Hospital

    lead OTHER

Principal Investigators

  • Takashi Uruno, MD · Ito Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01805856 on ClinicalTrials.gov